Viaskin Milk Patch Returns Mixed Results in Phase 1/2 Trial

Viaskin milk patch shows promise in cow’s milk allergy, particularly in children aged 2-11 with 300 μg dose, though the other doses examined failed to prove significant benefit.

Related Keywords

, Drug Administration , Children With Cow , Milk Allergy , Randomized Clinical , Viaskin Milk , Food Allergy , Aaaai 2024 , Viaskin , Epicutaneous Immunotherapy ,